Low HDL-cholesterol levels predict hepatocellular carcinoma development in individuals with liver fibrosis.
JHEP Rep
; 5(1): 100627, 2023 Jan.
Article
in En
| MEDLINE
| ID: mdl-36561127
ALP, alkaline phosphatase; ALT, alanine aminotransferase; APRI score; APRI, AST-to-platelet ratio index; AST, aspartate aminotransferase; CVR, cardiovascular risk; FA, fatty acid; FIB-4, fibrosis-4; GGT, gamma-glutamyltransferase; HCC, hepatocellular carcinoma; HDL-c, HDL-cholesterol; HbA1c, glycated haemoglobin; LXRs, liver X receptors; MetS, metabolic syndrome; Metabolic syndrome; NAFLD; NAFLD, non-alcoholic fatty liver disease; NASH; NASH, non-alcoholic steatohepatitis; RCT, reverse cholesterol transport; TG, triglyceride; Vitamin D; WC, waist circumference; Waist circumference
Full text:
1
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
JHEP Rep
Year:
2023
Type:
Article
Affiliation country:
Italy